Business Description
ProMIS Neurosciences is a Canadian biotech company focused on treating brain diseases caused by abnormally folded proteins, such as Alzheimer's, ALS, and several other neurological conditions. The company uses its own proprietary software tools to identify precise targets on these harmful proteins, enabling the development of antibody treatments and vaccines designed to slow or stop disease progression. Its pipeline includes several drug candidates at various stages of development, each aimed at a specific protein-related disease mechanism. The company is based in Toronto and was previously known as Amorfix Life Sciences before rebranding in 2015.
